科学平台
GAIA
肝靶向平台
延长给药间隔，以提高患者依从性
系统给药，皮下注射
创新的GalNAc修饰与化学修饰，以提升药效与安全性
APOLLO
中枢神经局部递送平台
小分子偶联，实现中枢神经系统内高效的受体介导摄取
局部给药，鞘内注射，以最大限度降低全身暴露相关的副作用
有望实现每六个月给药一次或更长的给药周期，且在非人灵长类动物中已获得概念验证
Bi-Valent/Multi-Valent
药物发现平台
适用于心血管疾病、肥胖症等多因素引发的复杂疾病
可针对两种或两种以上疾病
协同增效，且无额外副作用
相较于固定剂量复方制剂，研发路径更简洁，市场潜力更优
Jinyu Huang, Ph.D.
Chief Executive Officer, Founder
Stella Shi is founder, Chief Executive Officer and chairs the board of Rona Therapeutics since company inception in 2021 bringing ~15 years of biopharmaceutical industry and venture capital experience. Prior to founding Rona Therapeutics, Stella was managing director in Lilly Asia Ventures (LAV) from 2015 with proven track records with various venture creation ...